{
  "claims": [
    {
      "id": 331439,
      "index": 1,
      "node_name": "claim 1",
      "node_value": "A method of treating a disease caused or associated with the presence of pathological cells which are sensitive of γδ T cell lysis, comprising administering a composition comprising a compound according to formula:&#10;&#10;&#10;&#10;wherein Cat+ represents one or more cation, that can be the same or different, selected from proton(s), organic cation(s) or mineral cation(s);&#10;m is an integer from 1 to 3;&#10;B is O, NH, or any other group capable of being hydrolyzed;&#10;A is O, NH, CHF, CF2 or CH2, or any other isosteric group;&#10;W is C—R6 or N;&#10;R7 is a (C1-C3)alkyl group or any other isosteric group such as CF3;&#10;R3, R4, and R6 identical or different, are a hydrogen or a (C1-C3)alky group;&#10;R5 is an (C2-C3)acyl, an aldehyde, an (C1-C3)alcohol, or an (C2-C3)ester; and,&#10;Y═O−Cat+, a C1-C3 alky group, a group -A-R, wherein R is a linear, branched, or cyclic, aromatic or not, saturated or unsaturated, C1-C50 hydrocarbon group, optionally interrupted by at least one heteroatom, wherein said hydrocarbon group comprises an alkyl, an alkylenyl or an alkynyl which can be substituted by one or several substituents selected from the group consisting of: an alkyl, an alkylenyl, an alkylnyl, an epoxyalkyl, an aryl, an heterocycle, an alkoxy, an acyl, an alcohol, a carboxylic group (—COOH), an ester, an amine, an amino group (—NH2), an amide (—CONH2), an imine, a nitrile, an hydroxyl (—OH), a aldehyde group (—CHO), an halogen, an halogenoalkyl, a thiol (—SH), a thioalkyl, a sulfone, a sulfoxide, and a combination thereof.",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    },
    {
      "id": 331442,
      "index": 2,
      "node_name": "claim 2",
      "node_value": "The method according to claim 1, wherein said disease is a cancer, an autoimmune disease or an allergic disease.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 331445,
      "index": 3,
      "node_name": "claim 3",
      "node_value": "The method according to claim 2, wherein said cancer is selected from the group consisting of melanoma, ovarian cancer, pancreas cancer, neuroblastoma, head and neck cancer, bladder cancer, renal cancer, brain cancer, gastric cancer, lung cancer, colorectal cancer, prostate cancer and breast cancer.",
      "link_degree": 1,
      "references": [
        2
      ],
      "group": 1
    },
    {
      "id": 331448,
      "index": 4,
      "node_name": "claim 4",
      "node_value": "The method according to claim 2, wherein said autoimmune disease is selected from diabetes, multiple sclerosis and rheumatoid arthritis.",
      "link_degree": 1,
      "references": [
        2
      ],
      "group": 1
    },
    {
      "id": 331451,
      "index": 5,
      "node_name": "claim 5",
      "node_value": "The method according to claim 2, wherein said allergic disease is selected from asthma and airway hyperresponsiveness.",
      "link_degree": 1,
      "references": [
        2
      ],
      "group": 1
    },
    {
      "id": 331454,
      "index": 6,
      "node_name": "claim 6",
      "node_value": "The method according to claim 1, wherein said compound is administered conjointly with a cytokine.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 331457,
      "index": 7,
      "node_name": "claim 7",
      "node_value": "The method according to claim 7, wherein said cytokine is IL-2.",
      "link_degree": 1,
      "references": [
        7
      ],
      "group": 1
    },
    {
      "id": 331460,
      "index": 8,
      "node_name": "claim 8",
      "node_value": "A method of regulating the activity of γδ T cells in a human subject, said method comprising the steps of administering, in at least one treatment, a therapeutically effective amount of a compound of formula&#10;&#10;&#10;&#10;wherein Cat+ represents one or more cation, that can be the same or different, selected from proton(s), organic cation(s) or mineral cation(s);&#10;m is an integer from 1 to 3;&#10;B is O, NH, or any other group capable of being hydrolyzed;&#10;A is O, NH, CHF, CF2 or CH2, or any other isosteric group;&#10;W is C—R6 or N;&#10;R7 is a (C1-C3)alkyl group or any other isosteric group such as CF3;&#10;R3, R4, and R6 identical or different, are a hydrogen or a (C1-C3)alky group;&#10;R5 is an (C2-C3)acyl, an aldehyde, an (C1-C3)alcohol, or an (C2-C3)ester; and,&#10;Y═O−Cat+, a C1-C3 alky group, a group -A-R, wherein R is a linear, branched, or cyclic, aromatic or not, saturated or unsaturated, C1-C50 hydrocarbon group, optionally interrupted by at least one heteroatom, wherein said hydrocarbon group comprises an alkyl, an alkylenyl or an alkynyl which can be substituted by one or several substituents selected from the group consisting of: an alkyl, an alkylenyl, an alkylnyl, an epoxyalkyl, an aryl, an heterocycle, an alkoxy, an acyl, an alcohol, a carboxylic group (—COOH), an ester, an amine, an amino group (—NH2), an amide (—CONH2), an imine, a nitrite, an hydroxyl (—OH), a aldehyde group (—CHO), an halogen, an halogenoalkyl, a thiol (—SH), a thioalkyl, a sulfone, a sulfoxide, and a combination thereof, optionally together with a pharmaceutically acceptable carrier.",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    },
    {
      "id": 331463,
      "index": 9,
      "node_name": "claim 9",
      "node_value": "The method according to claim 8, wherein said compound is administered in a dosage between about 1 μg/kg and 1.2 g/kg.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331466,
      "index": 10,
      "node_name": "claim 10",
      "node_value": "The method according to claim 8, wherein said compound is administered in a dosage between about 10 μg/kg and 1.2 g/kg.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331469,
      "index": 11,
      "node_name": "claim 11",
      "node_value": "The method according to claim 1, wherein said compound is administered in a dosage between about 2 μg/kg and 100 mg/kg.",
      "link_degree": 1,
      "references": [
        1
      ],
      "group": 1
    },
    {
      "id": 331472,
      "index": 12,
      "node_name": "claim 12",
      "node_value": "The method according to claim 8, wherein said compound is administered conjointly with a cytokine.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331475,
      "index": 13,
      "node_name": "claim 13",
      "node_value": "The method according to claim 12, wherein said cytokine is IL-2.",
      "link_degree": 1,
      "references": [
        12
      ],
      "group": 1
    },
    {
      "id": 331478,
      "index": 14,
      "node_name": "claim 14",
      "node_value": "The method according to claim 8, wherein said compound is administered in a dosage between about 1 μg/kg and 1.2 g/kg.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331481,
      "index": 15,
      "node_name": "claim 15",
      "node_value": "The method according to claim 8, wherein said compound is administered in a dosage between about 10 μg/kg and 1.2 g/kg.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331484,
      "index": 16,
      "node_name": "claim 16",
      "node_value": "The method according to claim 8, wherein said compound is administered in a dosage between about 2 μg/kg and 100 mg/kg.",
      "link_degree": 1,
      "references": [
        8
      ],
      "group": 1
    },
    {
      "id": 331487,
      "index": 17,
      "node_name": "claim 17",
      "node_value": "A composition comprising a compound of formula&#10;&#10;&#10;&#10;wherein Cat+ represents one or more cation, that can be the same or different, selected from proton(s), organic cation(s) or mineral cation(s);&#10;m is an integer from 1 to 3;&#10;B is O, NH, or any other group capable of being hydrolyzed;&#10;A is O, NH, CHF, CF2 or CH2, or any other isosteric group;&#10;W is C—R6 or N;&#10;R7 is a (C1-C3)alkyl group or any other isosteric group such as CF3;&#10;R3, R4, and R6 identical or different, are a hydrogen or a (C1-C3)alky group;&#10;R5 is an (C2-C3)acyl, an aldehyde, an (C1-C3)alcohol, or an (C2-C3)ester; and,&#10;Y═O−Cat+, a C1-C3 alky group, a group -A-R, wherein R is a linear, branched, or cyclic, aromatic or not, saturated or unsaturated, C1-C50 hydrocarbon group, optionally interrupted by at least one heteroatom, wherein said hydrocarbon group comprises an alkyl, an alkylenyl or an alkynyl which can be substituted by one or several substituents selected from the group consisting of: an alkyl, an alkylenyl, an alkylnyl, an epoxyalkyl, an aryl, an heterocycle, an alkoxy, an acyl, an alcohol, a carboxylic group (—COOH), an ester, an amine, an amino group (—NH2), an amide (—CONH2), an imine, a nitrile, an hydroxyl (—OH), a aldehyde group (—CHO), an halogen, an halogenoalkyl, a thiol (—SH), a thioalkyl, a sulfone, a sulfoxide, and a combination thereof, wherein said composition prevents or is a treatment against a tumor, and optionally an antigen",
      "link_degree": 1,
      "references": [
        0
      ],
      "group": 1
    },
    {
      "id": 331490,
      "index": 18,
      "node_name": "claim 18",
      "node_value": "The composition according to claim 17, wherein said antigen is selected from Mycobacterium bovis; a tumoral antigen; an inactivated or attenuated pathogen, microorganism or parasite; an enriched or purified polypeptide; a lipid; a polysaccharide; a glycoprotein; a glycolipid; or a nucleic acid antigen.",
      "link_degree": 1,
      "references": [
        17
      ],
      "group": 1
    }
  ],
  "claim_links": [
    {
      "source": 331442,
      "target": 331439,
      "value": 1
    },
    {
      "source": 331445,
      "target": 331442,
      "value": 1
    },
    {
      "source": 331448,
      "target": 331442,
      "value": 1
    },
    {
      "source": 331451,
      "target": 331442,
      "value": 1
    },
    {
      "source": 331454,
      "target": 331439,
      "value": 1
    },
    {
      "source": 331457,
      "target": 331457,
      "value": 1
    },
    {
      "source": 331463,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331466,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331469,
      "target": 331439,
      "value": 1
    },
    {
      "source": 331472,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331475,
      "target": 331472,
      "value": 1
    },
    {
      "source": 331478,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331481,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331484,
      "target": 331460,
      "value": 1
    },
    {
      "source": 331490,
      "target": 331487,
      "value": 1
    }
  ],
  "links": {
    "is_parentChem_of": [
      {
        "source": 331442,
        "target": 331448,
        "source_value": "autoimmune disease",
        "target_value": "rheumatoid arthritis"
      }
    ]
  }
}